« Previous
Next »
Journal of Cataract & Refractive Surgery
Volume 31, Issue 11
, Pages 2142-2146
, November 2005
Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device
References
- Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study; the Endophthalmitis Vitrectomy Study Group. Am J Ophthalmol. 1996;122:1–17correction, 920
- . Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother. 1997;40:639–651
- The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol. 1989;108:380–386correction, 1991; 112:478–479
- . Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463–466
- Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500–505
- . Collagen shield delivery of ofloxacin to the human eye. J Cataract Refract Surg. 1999;25:562–565
- . Collagen corneal shields. Surv Ophthalmol. 2002;47:174–182
- An experimental study on the effect of collagen shields and therapeutic contact lenses on corneal wound healing. Cornea. 1996;15:612–616
- Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor. J Cataract Refract Surg. 1988;14:500–504
- . Collagen-shield delivery of gentamicin and vancomycin. Arch Ophthalmol. 1988;106:1599–1604
- . Enhancement of the ocular bioavailability of topical tobramycin with use of a collagen shield. J Cataract Refract Surg. 1993;19:242–245
- Use of collagen corneal shields versus soft contact lenses to enhance penetration of topical tobramycin. J Cataract Refract Surg. 1988;14:505–507
- . Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology. 2002;109:13–24
- Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol. 2005;123:39–44
- . Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing. J Chromatogr B Biomed Sci Appl. 1997;702:163–174
- Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999;106:1665–1670
- . Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. J Ocul Pharmacol Ther. 1997;13:31–40
- . Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol. 2003;136:300–305
Presented in part at the 140th Annual Meeting of the American Ophthalmological Society, Hot Springs, Virginia, May 2004.Supported by the Retina Research and Development Foundation, St. Louis, Missouri, USA.No author has a financial or proprietary interest in any material or method mentioned.
PII: S0886-3350(05)00675-9
doi: 10.1016/j.jcrs.2005.04.028
© 2005 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Cataract & Refractive Surgery
Volume 31, Issue 11
, Pages 2142-2146
, November 2005
